case_images: PMC3568912_01
case_images: MRI evidence of leptomeningeal carcinomatosis before treatment with IT trastuzumab.
case_images: CRIM.ONCMED2013-154674.001.jpg
case_images: PMC3568912_01_CRIM.ONCMED2013-154674.001.jpg
case_images: fig1
case_images: However spinal MRI showed multiple leptomeningeal lesions (see Figure 1).
case_images: Decreased values until normal ranges of the CSF protein level with IT trastuzumab. First value corresponds to the lumbar punction. The next values corresponds to the Ommaya reservoir functions.
case_images: CRIM.ONCMED2013-154674.002.jpg
case_images: PMC3568912_01_CRIM.ONCMED2013-154674.002.jpg
case_images: fig2
case_images: The protein level decreased until normal values (0.15-0.45 g/L) after the fourth dose (see Figures 2 and 3).
case_images: Decreased values of the proteins in the CSF by Ommaya punction, during the treatment with IT trastuzumab.
case_images: CRIM.ONCMED2013-154674.003.jpg
case_images: PMC3568912_01_CRIM.ONCMED2013-154674.003.jpg
case_images: fig3
case_images: The protein level decreased until normal values (0.15-0.45 g/L) after the fourth dose (see Figures 2 and 3).